Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 271-280

  Ridet, Jean Luc ^a,b,c   Corti, Olga ^a   Pencalet, Philippe ^a   Hanoun, Naïma ^a   Hamon, Michel ^a   Philippon, Jacques ^a   Mallet, Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Division of Surgical Research and Gene Therapy Center   (Switzerland)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; LEVODOPA; TETRACYCLINE; TYROSINE 3 MONOOXYGENASE; VIRUS VECTOR;

ADENOVIRUS; ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; AUTOTRANSPLANTATION; CELL PROLIFERATION; CELL SECRETION; CELL TRANSPLANTATION; CELL TYPE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NERVE CELL CULTURE; TIME; TRANSGENE;

ADENOVIRIDAE; ADULT; AGED; ASTROCYTES; CELL DIVISION; CELL TRANSPLANTATION; CELLS, CULTURED; CEREBRAL CORTEX; FREEZING; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TETRACYCLINES; TYROSINE 3-MONOOXYGENASE;

EID: 0033585426     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019057     Document Type: Article

References (50)

1. 1A receptors in brain. J. Pharmacol. Exp. Ther. 248, 1222-1230.
2. ALOISI, F., BORSELLINO, G., SAMOGGIA, P., TESTA, U., CHELUCCI, C., RUSSO, G., PESCHLE, C., and LEVI, G. (1992). Astrocyte cultures from human embryonic brain: Characterization and modulation of surface molecules by inflammatory cytokines. J. Neurosci. Res. 32, 494-506.
3. ANDERSSON, C., TYTELL, M., and BRUNSO-BECHTLOD, J. (1993). Transplantation of cultured type 1 astrocyte cell suspensions into young, adult and aged rat cortex: Cell migration and survival. Int. J. Dev. Neurosci. 11, 555-568.
4. AUBERT, I., RIDET, J.L., and GAGE, F.H. (1995). Regeneration in the adult mammalian CNS: Guided by development. Curr. Opin. Neurobiol. 5, 625-635.
5. BARKATS, M., BILANG-BLEUEL, A., BUC-CARON, M.H., CASTEL-BARTHE, M.N., CORTI, O., FINIELS, F., HORELLOU, P., REVAH, F., SABATE, O., and MALLET, J. (1998). Adenovirus in the brain: Recent advances of gene therapy for neurodegenerative diseases. Prog. Neurobiol. 55, 333-341.
6. BILANG-BLEUEL, A., REVAH, F., COLIN, P., LOCQUET, I., ROBERT, J.J., MALLET, J., and HORELLOU, P. (1997). Intrastrial injection of an adenoviral vector expressing GDNF prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 94, 8818-8823.
7. BOOSS, J., SOLLY, K.S., COLLINS, P.V., and JACQUE, C. (1991). Migration of xenogenic astrocytes in myelinated tracts: A novel probe for immune responses in white matter. Acta Neuropathol. 82, 172-177.
8. CASTILLO, B., JR., DEL CERRO, M., BREAKEFIELD, X.O., FRIM, D.M., BARNSTABLE, C.J., DEAN, D.O., and BOHN, M.C. (1994). Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF). Brain Res. 647, 30-37.
9. CORTI, O., HORELLOU, P., COLIN, P., CATTANEO, E., and MALLET, J. (1996). Intracerebral tetracycline-dependent regulation of gene expression in grafts of neural precursors. NeuroReport 7, 1655-1659.
10. CUNNINGHAM, L.A., HANSEN, J.T., SHORT, M.P., and BOHN, M.C. (1991). The use of genetically altered astrocytes to provide nerve growth factor (NGF) to adrenal chromaffin cell grafted into the striatum. Brain Res. 561, 192-202.
11. CUNNINGHAM, L.A., SHORT, M.P., BREAKEFIELD, X.O., and BOHN, M.C. (1994). Nerve growth factor released by transgenic astrocytes enhanced the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease. Brain Res. 558, 219-223.
12. FISHER, L.J. (1997). Neural precursor cells: Applications for the study and repair of the central nervous system. Neurobiol. Dis. 4, 1-22.
13. FISHER, L.J., and GAGE, F.H. (1993). Grafting in the mammalian central nervous system. Physiol. Rev. 73, 583-616.
14. FISHER, L.J., JINNAH, H.A., KALE, L.C., HIGGINS, G.A., and GAGE, F.H. (1991). Survival and function of intrastriatally grafted fibroblasts genetically modified to produce L-DOPA. Neuron 6, 371-380.
15. FRITSCHY, J.M., BRANDNER, S., AGUZZI, A., KOEDOOD, M., LUSCHER, B., and MITCHELL, P.J. (1996). Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice. J. Neurosci. 16, 2275-82.
16. GAGE, F.H., RAY, J., and FISHER, L.J. (1995). Isolation, characterization and use of stem cells from the CNS. Annu. Rev. Neurosci. 18, 159-192.
17. GOODMAN, J.C., TRASK, T.W., CHEN, S.H., WOO, S.L.C., GROSSMAN, R.G., CAREY, K.D., HUBBARD, G.B., CARRIER, D.A., RAJAGOPALAN, S., AGUILAR-CORDOVA, E., and SHINE, H.D. (1996). Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: Pathologic, radiologic, and molecular studies. Hum. Gene Ther. 7, 1241-1250.
18. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551.
19. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MULLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
20. HORELLOU, P., BRUNDIN, P., KALEN, P., MALLET, J., and BJÖRKLUND, A. (1990a). In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated striatum. Neuron 5, 393-402.
21. HORELLOU, P., MARLIER, L., PRIVAT, A., and MALLET, J. (1990b). Behavioral effect of engineered cells that synthesize L-dopa or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2, 116-119.
22. HORELLOU, P., VIGNE, E., CASTEL, M.N., BARNEOUD, P., COLIN, P., PERRICAUDET, M., DELAERE, P., and MALLET, J. (1994). Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. NeuroReport 6, 49-53.
23. JACQUE, C., QUINONERO, J., COLLINS, P.V., VILLARROYA, H., and SUARD, I. (1992). Comparative migration and development of astroglial and oligodendroglial cell populations from a brain xenograft. J. Neurosci. 12, 3098-3106.
24. JUORIO, A.V., LI, X.M., WALZ, W., and PATERSON, I.A. (1993). Decarboxylation of L-dopa by cultured mouse astrocytes. Brain Res. 626, 306-309.
25. KISTNER, A., GOSSEN, M., ZIMMERMANN, F., JERECIC, J., ULLMER, C., LUBBERT, H., and BUJARD, H. (1996). Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93, 10933-10938.
26. LA GAMMA, E.F., WIESINGER, G., LENN, N.J., and STRECKER, R.E. (1993). Genetically modified primary astrocytes as cellular vehicles for gene therapy in the brain. Cell Transplant. 2, 207-214.
27. LEVALLOIS, C., MALLET, J., and PRIVAT, A. (1996). An adenovirus vector encoding tyrosine hydroxylase activity may enter human CNS cells in primary dissociated cultures. Int. J. Dev. Neurosci. 14, 613-619.
28. LIN, Q., CUNNINGHAM, L.A., EPSTEIN, L.G., PECHAN, P.A., SHORT, M.P., FLEET C., and BOHN, M.C. (1997). Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor. Hum. Gene Ther. 8, 331-339.
29. LUNDBERG, C., HORELLOU, P., MALLET, J., and BJÖRKLUND, A. (1996). Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro characterization and in vivo effects in the rat Parkinson model. Exp. Neurol. 139, 39-53.
30. MARON, A., HAVAUX, N., LE ROUX, A., KNOOPS, B., PERRICAUDET, M., and OCTAVE, J.N. (1997). Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene. Gene Ther. 4, 25-31.
31. MARTINEZ-SERRANO, A., and BJORKLUND, A. (1997). Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci. 20, 530-538.
32. MAYFORD, M., BACH, M.E., HUANG, Y.Y., WANG, L., HAWKINS, R.D., and KANDEL, E.R. (1996). Control of memory formation through regulated expression of a CAMKII transgene. Science 274, 1678-1683.
33. McCARTHY, M., WOOD, C., FEDOSEYEVA, L., and WHITTEMORE, S.C. (1995). Media components influence viral gene expression assays in human fetal astrocyte cultures. J. Neurovirol. 1, 275-285.
34. MILLER, N., and WHELAN, J. (1997). Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther. 8, 803-815.
35. OLANOW, C., KORDOWER, J.H., and FREEMAN, T.B. (1996). Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102-109.
36. PERZELOVA, A., and MARES, V. (1993). Appearance of GFAP-positive cells in adult human brain cultures spontaneously decelerated in growth. Glia 7, 237-244.
37. PUNDT, L.L., KONDOH, T., and LOW, W.C. (1995). The fate of human glial cells following transplantation in normal rodents and rodent models of neurodegenerative disease. Brain Res. 695, 25-36.
38. 3H]-tyrosine by charcoal. Life Sci. 39, 2185-2189.
39. RIDET, J.L., MALHOTRA, S.K., PRIVAT, A., and GAGE, F.H. (1997). Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci. 20, 570-577.
40. RIDOUX, V., ROBERT, J.J., ZHANG, X., PERRICAUDET, M., MALLET, J., and LE GAL LA SALLE, G. (1994). The use of adenovirus vectors for intracerebral grafting of transfected nervous cells. NeuroReport 5, 801-804.
41. SABATE, O., HORELLOU, P., VIGNE, E., COLIN, P., PERRICAUDET, M., BUCCARON, M.H., and MALLET, J. (1995). Transplantation to the rat brain of human neural progenitors that were genetically modified using adenovirus. Nature Genet. 9, 256-260.
42. SAEZ, E., NO., D., WEST, A., and EVANS, R.M. (1997). Inducible gene expression in mammalian cells and transgenic mice. Curr. Opin. Biotechnol. 8, 608-616.
43. STACHOWIAK, M.K., MOFFETT, J., MAHER, P., TUCHOLSKI, J., and STACHOWIAK, E.K. (1997). Growth factor regulation of cell growth and proliferation in the nervous system. Mol. Neurobiol. 15, 257-283.
44. STREIT, W.J. (1990). An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J. Histochem. Cytochem. 38, 1683-1686.
45. TAYLOR, R. (1997). Cell vehicles for gene transfer to the brain. Neuromusc. Dis. 7, 343-351.
46. WOLFF, J.F., FISHER, L.J., XU, L., JINNAH, H.A., LANGLAIS, P.J., IUVONE, P.M., O'MALLEY, K.L., ROSENBERG, M.B., SHIMOHAMA, S., FRIEDMANN, T., and GAGE, F.H. (1989). Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 86, 9011-9014.
47. YONG, V.W., MOUMDJIAN, R., YONG, F.P., RUIJS, T.C.G., FREEDMAN, M.S., CASHMAN, N., and ANTEL, J.P. (1991). Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc. Natl. Acad. Sci. U.S.A. 88, 7016-7020.
48. YONG, V.W., TEJADA-BERGES, T., GOODYER, C.G., ANTEL, J.P., and YONG, F.P. (1992). Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia 6, 269-280.
49. YOSHIMOTO, Y., LIN, Q., COLLIER, T., FRIM, D., BREAKEFIELD, X.O., and BOHN, M.C. (1995). Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691, 25-36.
50. YU, J.S., SENA-ESTEVES, M., PAULUS, W., BREAKEFIELD, X.O., and REEVES, S.A. (1996). Retroviral delivery and tetracycline-dependent expression of IL-1beta-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells. Cancer Res. 56, 5423-5427.